{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2007"],"condition":["Gastrointestinal Neoplasm","Lung Cancer","Gastrointestinal Neoplasms","Solid Tumor","Sarcoma","Colorectal Cancer","Head and Neck Cancer","Bladder Cancer","Pancreatic Cancer","Breast Cancer","Ovarian Cancer","Prostate Cancer","Digestive System Neoplasms","Cancer"],"disease":["Gastrointestinal Neoplasm","Lung Cancer","Solid Tumor","Gastrointestinal Neoplasms","Sarcoma","Colorectal Cancer","Bladder Cancer","Pancreatic Cancer","Breast Cancer","Ovarian Cancer","Prostate Cancer","Head And Neck Cancer","Digestive System Neoplasms","Cancer"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2039408"],"location":["United States"],"study_start_month":["4"],"keyword":["Neoplasm","Picoplatin","Chemotherapy","Advanced","Platinum","Tumor"],"repository":["ECRIN MDR"],"study_status":["Completed"],"additional_accession":[]},"is_claimable":false,"name":"A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors","description":"Picoplatin is a new platinum-based chemotherapy drug that has been studied in a variety of cancers. Phase 1 and 2 studies have demonstrated that picoplatin may be effective in patients whose cancer returns or does not improve after treatment with chemotherapy. In these studies, picoplatin was administered intravenously. A capsule containing picoplatin has been formulated. This study will investigate the activity of the oral capsule in humans. Participants with advanced solid tumors will be enrolled.","dates":{"creation":"2007-04-15"},"accession":"2039408","cross_references":{"ClinicalTrials___gov":["NCT00465725"]}}